Martin Himmel
Vice President Regulatory Affairs at Syremis Therapeutics
📍 Israel
Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.
Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.
Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.
Experience
36 Years
Current Role
Vice President Regulatory Affairs
Job Level
Senior
Location
Israel
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Martin cares about
Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Career
Work history
12-2025
Vice President Regulatory Affairs
Syremis Therapeutics
3-2023
VP of Regulatory Affairs
Clexio Biosciences
8-2018 - 4-2023
Head Of Regulatory Affairs
Clexio Biosciences
1-2014 - 2018
Executive Director, Biopharm, Regulatory Affairs
Novo Nordisk
8-2012 - 10-2013
Executive Director, Global Regulatory Affairs
Merck
In the press
Media appearances
Media appearances and press coverage highlighting public visibility and thought leadership.
Login to viewLogin to view media
Education
MD
Albert Einstein College of Medicine
MPH
Johns Hopkins University School of Public Health and Hygiene
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.